RCHY1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.487600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.394400E-01
Normal-vs-Stage2
2.402300E-02
Normal-vs-Stage3
1.454120E-02
Normal-vs-Stage4
6.307800E-01
Stage1-vs-Stage2
6.017800E-02
Stage1-vs-Stage3
2.475800E-02
Stage1-vs-Stage4
9.757000E-01
Stage2-vs-Stage3
2.390800E-01
Stage2-vs-Stage4
1.427420E-01
Stage3-vs-Stage4
2.206400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.547900E-02
Normal-vs-AfricanAmerican
3.710000E-01
Normal-vs-Asian
5.542200E-02
Caucasian-vs-AfricanAmerican
2.833600E-01
Caucasian-vs-Asian
3.301800E-01
AfricanAmerican-vs-Asian
1.638170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.327700E-02
Normal-vs-Female
6.505800E-02
Male-vs-Female
5.535800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.529000E-01
Normal-vs-Age(41-60Yrs)
1.425570E-01
Normal-vs-Age(61-80Yrs)
5.684000E-02
Normal-vs-Age(81-100Yrs)
1.031900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.337400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.220200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.890840E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.111700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.557900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.806600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.124900E-03
Normal-vs-Daily Drinker
9.583600E-03
Normal-vs-Weekly Drinker
1.942000E-02
Normal-vs-Occasional Drinker
2.126000E-01
Normal-vs-Social Drinker
1.760410E-01
Non Drinker-vs-Daily Drinker
6.993400E-01
Non Drinker-vs-Weekly Drinker
7.298000E-01
Non Drinker-vs-Occasional Drinker
1.391960E-02
Non Drinker-vs-Social Drinker
1.691770E-01
Daily Drinker-vs-Weekly Drinker
9.914800E-01
Daily Drinker-vs-Occasional Drinker
1.481910E-02
Daily Drinker-vs-Social Drinker
1.444190E-01
Weekly Drinker-vs-Occasional Drinker
3.467900E-02
Weekly Drinker-vs-Social Drinker
2.099000E-01
Occasional Drinker-vs-Social Drinker
5.169600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.109800E-01
Normal-vs-Grade 2
1.386280E-02
Normal-vs-Grade 3
4.187800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.841600E-01
Grade 1-vs-Grade 3
4.815000E-01
Grade 1-vs-Grade 4
1.109800E-01
Grade 2-vs-Grade 3
9.158400E-01
Grade 2-vs-Grade 4
1.386280E-02
Grade 3-vs-Grade 4
4.187800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.541500E-03
Normal-vs-NonDiabetic
6.345500E-02
Diabetic-vs-NonDiabetic
1.842390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.297570E-03
Normal-vs-NoPancreatitis
5.864000E-02
Pancreatitis-vs-NoPancreatitis
4.401600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.262200E-01
Normal-vs-N1
2.561800E-02
N0-vs-N1
3.223400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.787600E-02
Normal-vs-TP53-NonMutant
4.369800E-01
TP53-Mutant-vs-TP53-NonMutant
8.851800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
